Cargando…
Safety of 50,000-100,000 Units of Vitamin D3/Week in Vitamin D-Deficient, Hypercholesterolemic Patients with Reversible Statin Intolerance
BACKGROUND: Vitamin D deficiency (<32 ng/mL) is a reversible cause of statin-intolerance, usually requiring vitamin D3 (50,000-100,000 IU/week) to normalize serum D, allowing reinstitution of statins. Longitudinal safety assessment of serum vitamin D, calcium, and estimated glomerular filtration...
Autores principales: | Jetty, Vybhav, Glueck, Charles J, Wang, Ping, Shah, Parth, Prince, Marloe, Lee, Kevin, Goldenberg, Michael, Kumar, Ashwin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821095/ https://www.ncbi.nlm.nih.gov/pubmed/27114973 http://dx.doi.org/10.4103/1947-2714.179133 |
Ejemplares similares
-
Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dl despite maximal tolerated cholesterol lowering therapy
por: Glueck, Charles J., et al.
Publicado: (2016) -
Eligibility for alirocumab or evolocumab treatment in 1090 hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dL despite maximal-tolerated LDL-cholesterol-lowering therapy
por: Jetty, Vybhav, et al.
Publicado: (2017) -
Statin Intolerance and Vitamin D Supplementation
por: Khayznikov, Maksim, et al.
Publicado: (2015) -
Associations between Serum 25-hydroxyvitamin D and Lipids, Lipoprotein Cholesterols, and Homocysteine
por: Glueck, Charles J., et al.
Publicado: (2016) -
$100,000 Premium
Publicado: (1883)